PAVM · CIK 0001624326 · FY2025 live · 2025-12-31
PAVmed Inc.
View as
Model
Classic Z
FY2025
−10.33
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−10.33
Z″ −25.42
Score −10.33 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
−0.321.2 × = −0.38X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−6.671.4 × = −9.33X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.563.3 × = −1.85X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
2.060.6 × = 1.23X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
PAVmed Inc. is on classic Z at −10.33 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 16th percentile in Healthcare.
- NCELDistressNewcelX Ltd.−10.19
- NEPHDistressNEPHROS INC−10.51
- CTSODistressCytosorbents Corp−10.61
- STRODistressSUTRO BIOPHARMA, INC.−10.03
- LONADistressLeonaBio, Inc.−10.63
- SHPHDistressShuttle Pharmaceuticals Holdings, Inc.−10.63
- HRTXDistressHERON THERAPEUTICS, INC. /DE/−9.94
- CRDFDistressCardiff Oncology, Inc.−9.83
KPI widgets
Current assets
$3M
Total assets
$39M
Current liabilities
$15M
Total liabilities
$17M
Working capital
−$12M
Retained earnings
−$259M
EBIT
−$22M
Total sales
$71K
Book equity
$34M
Accession 0001437749-26-010115. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.